“Out of respect for the 33rd,” an employee of Tallmin Medical’s representative in Russia told a BIC journalist, explaining the discount. The journalist was posing as someone collecting equipment for Russian servicemen. The 33rd Regiment is involved in fighting in Ukraine’s Donetsk region. The company’s hemostatic products end up in Russian military units in Ukraine. Meanwhile, military medics publicly thank “the guys” linked to the manufacturer for providing the products free of charge. We discovered that a company based in Estonia holds a controlling stake in the Belarusian enterprise.
The investigation was conducted with the support of Rabochy Ruch and assistance from CyberPartisans.
“Tallmin Bel is the most effective solution at a stabilization point, which is why we were specifically raising [funds] to purchase it. We placed the order directly through the company’s representative in Russia — very pleasant, responsible people who are understanding of the situation (they offer discounts and even add extra at their own expense for the glory of the Motherland). I shake your hand.”
Such a message appeared in July on the Telegram channel of a volunteer group supporting the 33rd Guards Motor Rifle Regiment of the 20th Division of the Russian Armed Forces. At that time, in the summer of 2026, the unit participated in battles along the Dobropillia axis. This area is a key defensive node on the western flank of the Kramatorsk-Sloviansk fortification line.This regiment is not the only Russian military unit using the Belarusian hemostatic product Tallmin-Bel. We found online fundraising appeals by foundations in Moscow, Nizhnevartovsk, Kamyshin, Tyumen, and other Russian cities and regions for medical supplies for the front and frontline hospitals, in which Tallmin-Bel was mentioned [*].
Why servicemen need hemostatic products
Hemostatics are used to stop massive bleeding, which is one of the main causes of death among the wounded on the battlefield.
“With significant damage to the [arteries], within just a few dozen seconds a person ... loses the ability to provide help to themselves, and after a few minutes, death occurs as a result of severe blood loss,” a Kastus Kalinouski Regiment soldier who served in the medical unit told the BIC.
Such bleeding can be stopped by packing the wound with gauze or pads soaked in a hemostatic agent and applying pressure. Hemostatics have become especially important in drone warfare as evacuation of the wounded may be delayed.
A tourniquet can temporarily stop bleeding from a wounded limb. According to the BIC source, it should be applied for no more than two hours during the warm season and for no more than one hour during the cold season. Longer use increases the risk of tissue death and limb loss. If the wounded person’s condition allows, the tourniquet is replaced with hemostatic gauze to apply pressure to the wound. This process is called tourniquet conversion.
“If performed successfully, this procedure allows the soldier to save the limb,” explained the Kalinouski Regiment fighter.
“Out of respect for the 33rd”
The hemostatic product Tallmin-Bel is produced by the private Belarusian company Tallmin Medical. The company registered the product in 2020 and began producing its own hemostatic gauze and pads. State-run organizations later announced similar products of their own: Belarusian State University unveiled its hemostatic dressing in 2024, while the Republican Scientific and Practical Center for Transfusiology and Medical Biotechnology presented its version in 2025.
Public reports are not the only evidence that Tallmin Medical products are reaching the Russian military. The BIC discovered that Tallmin-Bel was supplied to the Pomoshch Svoim Foundation, which translates to “Helping Our Own” [*]. This foundation, based in Tatarstan, collects and sends equipment to the Russian military in Ukraine. In August 2024, the Belarusian manufacturer sent the foundation 17 kilograms of products, valued at approximately $2,500.
The BIC’s discovery of the delivery is not the only evidence of the company’s willingness to collaborate with those who collect supplies for the Russian military. A BIC journalist confirmed this firsthand. He called the number listed on the website of Avion, the Russian distributor of Tallmin Medical [*]. The person on the other end of the line confirmed that he was speaking on behalf of the “official and sole representative [of the Belarusian manufacturer] in Russia.”
“To be honest, Tallmin and we are one and the same.”
The BIC investigator introduced himself as someone who collects equipment for the Russian military. He referred to the 33rd Regiment, which is fighting in the Dobropillia area. In response, an Avion representative offered Tallmin-Bel at 850 Russian rubles per pack containing a 13.5 × 20 cm dressing, noting that the market price starts at 1,000 rubles. He explained that he was proposing a discount “out of respect for the 33rd” and offered to deliver the goods at his company’s expense to a convenient location via a popular courier service. The interlocutor’s words suggest that the company has experience sending goods to occupied territories.
“CDEK used to deliver to Debaltseve, for example, to the ‘LNR’ [Luhansk People’s Republic].”
The price offered to the journalist is nearly the same as the price at which hemostatics were collected for the medics of the 33rd Regiment. According to a post in the Telegram channel of the volunteer movement affiliated with the Regiment, the price is 866 Russian rubles per package. For comparison, the same package costs 1,705 Russian rubles (about €13.7) on Wildberries, a popular marketplace.
But evidence of cooperation isn’t just limited to discounted sales. We found public messages from representatives of organizations that provide equipment to Russian servicemen and military medics. They mentioned receiving Tallmin Medical products for free. In March 2025, the St. Petersburg-based Svarog Center for Special Training and Tactical Medicine thanked “friends from Tallmin-Bel” for the parcel of hemostatics they received. Representatives of the center reported on VK that the hemostatics would be sent as part of “humanitarian medical aid to the SMO zone.” [*]
The recipients themselves have also written about free supplies being provided directly to military medics. The authors of the Telegram channel Kakie-to Mediki thanked Tallmin Medical, saying that the company’s “guys” had been “sending us their hemostatic materials free of charge for our work for a long time.”
The company Avion, which represents Tallmin Medical in Russia, does not hide its contacts with this audience. In thematic communities, company employees respond to criticism, compare Tallmin-Bel to competitors’ products, and offer samples of the Tallmin-Bel hemostatic [*].
Estonian owner
Tallmin Medical is headed by Aleh Bobryk, a former military doctor with experience in Belarusian military structures. He headed a military hospital in Barysau at various times and worked at the Military Academy of Belarus and the Republican Hospital of the Ministry of Internal Affairs.
Almost half of the company belongs to two Belarusians. Ten percent belongs to Yury Kudzin, a former employee of the MIA Directorate for Combating Organized Crime and Corruption — the predecessor of GUBAZiK (Main Directorate for Combating Organized Crime and Corruption). The remaining 39% belongs to Mikalai Charnyshou, a businessman who served as deputy director of Energo-Oil while the company was owned by the family of Aliaksei Aleksin. Aleksin is known in Belarus as the “tobacco king” and was sanctioned by the USA and the European Union in 2021. Charnyshou co-owned Avion, which sells Tallmin-Bel in Russia, until July 2024.
However, the company is not majority-owned by Belarusians. New Century Holding, a company registered in Estonia in 2014, owns a 51% stake in Tallmin Medical. New Century Holding’s majority owner is Estonian citizen Oleg Savtšenko.
Before Tallmin Medical’s establishment in 2019, New Century Holding did not conduct business. Its reports did not include information about subsidiaries or investments. According to available reporting, Belarusian company Tallmin Medical was its only subsidiary until at least 2024.
According to its representative, Tallmin Medical is preparing to expand its business in Russia. The BIC journalist learned this during the same conversation in which he introduced himself as a potential buyer.
“A little later, we’ll have another brand in Russia… I think it’ll be in Russia within literally a month or two. It’ll be the same product, with the same quality.”
European Business
The Estonian owner’s connection to the Belarusian co-owners of Tallmin Medical extends beyond this company. Oleg Savtšenko and Mikalai Charnyshou are also involved in another business in the European Union. Charnyshou is a board member and the sole owner of Fivecrew. This Estonian company owns half of Inccom, another Estonian company. Inccom, in turn, owns the French company Gelyne SAS, which produces agricultural products. Savtšenko became the second member of the Fivecrew board in February 2026.
Thus, a company from Estonia, an EU country, owns a controlling stake in the Belarusian manufacturer whose products are supplied to Russian servicemen. Its owner runs another business in the EU with one of the Belarusian co-owners of Tallmin Medical. To determine whether the described connections and supplies could have legal implications for the Estonian company and its owner, the BIC consulted Dmitry Kuravkin, an Estonian expert on financial sector compliance.
According to the expert, the Estonian company’s 51% ownership of Tallmin Medical does not automatically constitute a violation of the sanctions regime. However, under European Union legal norms, New Century Holding, as the parent structure, is obliged to make every effort to ensure that the company it controls does not violate sanctions restrictions.
“I can say that even the hypothetical possibility of such a violation, or the mere fact of cooperating with the Russian military, can have serious negative consequences for the company, regardless of whether a formal violation of sanctions legislation is proven. This primarily applies to reputational risks and public reaction, as well as relations with banks, which typically take a broader view of such connections.”
Kuravkin emphasized the importance of determining whether the Estonian company was aware of the Belarusian subsidiary’s and the Russian distributor’s activities, and whether it received information about clients and shipments. To find this out, a BIC journalist contacted Oleg Savtšenko, the majority owner of the Estonian holding. The investigative journalist introduced himself as someone who collects equipment for the Russian military. He offered to write Savtšenko a letter of gratitude. Savtšenko called the topic a “sensitive issue” and noted that he lives in Estonia. Instead, Savtšenko suggested sending a letter of gratitude to Aleh Bobryk, a Belarusian citizen and the director of Tallmin Medical.
Seven minutes after the conversation ended, Savtšenko sent a message denying what he had said earlier. He emphasized that he was not connected to the business described and said he “didn’t really understand” what the interlocutor was talking about.
In addition to the undercover conversation, BIC sent requests for comment to Oleg Savtšenko, Aleh Bobryk, and Mikhail Lyubushkin, director of Tallmin Medical’s Russian distributor, asking them to comment on the supply of Tallmin-Bel hemostatics to Russian servicemen. At the time of publication, we had received no responses.